A wholesale line sheet can tell a buyer what a supplier wants to sell. It cannot establish what the product is, what the current batch contains, whether the label creates a working route to the evidence, or what happens when federal law changes on 2026-11-12. Those answers live in documents.
A useful supplier file in 2026 has four layers: batch evidence, label evidence, packaging evidence, and sales-control evidence. A fifth layer arrives on 2026-11-12, when the federal definition changes and the word “container” becomes a compliance variable. The sources reviewed through 2026-08-17 contained no FDA definition of that term.
General information, not a substitute for the advice of an attorney. Jurisdiction: Texas and United States federal law. Last verified: 2026-08-17.
The buyer file, at a glance
- Identity: exact product, form, strength, package configuration, batch, and dates.
- Laboratory evidence: a batch-specific COA from an ISO/IEC 17025 accredited laboratory, with the relevant panels and units.
- Label evidence: batch number and date, manufacturer contact, serving information, warnings, and a conspicuous route to the COA.
- Packaging evidence: the physical retail package, not a design mockup, showing tamper-evident and child-resistant construction and resealability where the product has multiple servings.
- Age-control evidence: a retail process capable of reviewing valid identification before a sale to a person under 21 is completed.
- Federal-transition evidence: total THC, cannabinoid origin, and the package layer treated as the container under the 2026-11-12 rule.
The Texas elements above come from 25 TAC ch. 300, including §§300.301, 300.402, 300.405, and 300.701, and from the policy direction in Executive Order GA-56. The federal transition comes from §781 of P.L. 119-37, summarized by the Congressional Research Service in IF13136.
Layer one: exact product identity
Compliance review begins before the laboratory table. The supplier file has to describe the same sellable unit the store receives: same brand, same product name, same form, same labelled strength, same package count or volume, and the same batch relationship.
Product-family evidence is not batch evidence. A COA for one flavour, package size, or formulation cannot establish another merely because the front label shares a logo. A report issued to another brand cannot establish the SKU being purchased. An old report can remain authentic while no longer describing the current formulation.
This is the control that catches the cleanest-looking bad file: a genuine laboratory report attached to the wrong item. The chemistry can be flawless and the evidence can still fail at identity.
Layer two: a batch-specific laboratory report
Texas requires consumable hemp to have a batch COA from an ISO/IEC 17025 accredited laboratory (25 TAC §300.301; Texas State Law Library cannabis guide). The required report includes the percentage of delta-9 THC, total delta-9 THC, and total THC per container (25 TAC §300.301(d)(12)).
Those three figures answer different questions. Delta-9 alone is one analyte. Total delta-9 includes the THCA conversion in the Texas calculation. Total THC per container is a package-level disclosure. The last figure is not a Texas milligram ceiling; Texas contains no per-serving or per-container milligram cap in 25 TAC ch. 300 and instead uses total delta-9 at or below 0.3% dry weight under §300.101(1) and §300.302(b).
A report also has a scope. Potency findings do not imply that contaminant panels were run. A “pass” applies to the named panel and its method, not to everything a retailer might associate with product quality. The panel list, reporting limits, and qualifiers remain part of the evidence.
Our guide to how to read the COA you are handed covers product matching, laboratory identity, units, ND, LOD, LOQ, and the difference between a measured value and a label claim.
Layer three: the label as an access system
Texas labels have to carry a batch number, batch date, manufacturer contact information, a recommended serving size in milligrams, servings per container, required warnings, and a conspicuous URL that reaches the COA in no more than three steps (25 TAC §300.402(a); Executive Order GA-56).
The label is therefore more than a list of claims. It is the bridge between the physical package and the evidence file. The batch identifier connects the item to the report. The URL or QR route gives the reader access. The serving information gives the unit against which label and laboratory values can be compared.
A design proof cannot complete this review. The real printed package reveals whether the code scans, the URL resolves, the text remains legible at production size, and the destination leads to the relevant product. A supplier can have a correct report and still fail to make it reachable from the package.
The QR code itself is not proof. It is an address. Our separate explanation of the Texas three-step rule distinguishes a printed square from a working route to batch evidence.
Layer four: packaging form
Texas requires consumable-hemp packaging to be tamper-evident and child-resistant, and multi-serving packaging has to be resealable (25 TAC §300.405; Executive Order GA-56). Those are properties of the retail package around the consumable.
A smell-proof carry bag is not the retail package and is not evidence that the package satisfies §300.405. FireBar Labs bags are field-tested carry goods. They are not certified child-resistant packaging, they are not laboratory-tested consumable containers, and placing a product inside one does not transfer a packaging certification to the product.
This distinction matters in merchandising. A lockable bag can provide household access control as a separate product category. It cannot be represented as the legal child-resistant package for a consumable. The regulated package and the carry good remain separate objects with separate claims.
Layer five: the 21-and-over gate
Texas prohibits selling, delivering, or offering consumable hemp to a minor and requires age verification by reviewing valid proof of identification before completing the sale; the rules define a minor as a person under 21 (25 TAC §300.701, §300.101(26); Executive Order GA-56).
The age gate lives in an agency rule rather than in HB 1325 itself. Texas Health & Safety Code ch. 443 contains no statutory age limit; the 21-and-over obligation was implemented through 25 TAC ch. 300 after Executive Order GA-56 (25 TAC §300.701; Executive Order GA-56).
For a retailer, the evidence question is operational: the point-of-sale process has to place identification review before completion of the sale. A sign stating “21+” describes the rule. It does not perform the review required by §300.701.
The Texas cannabinoid boundary changed on 2026-07-31
Texas republished its controlled-substances schedule through 51 TexReg 4597, effective 2026-07-31 under Tex. Health & Safety Code §481.034 (Texas Register notice). The notice carves out only delta-9 at or below 0.3% in hemp and places non-delta-9 THC isomers such as delta-8, delta-10, and THCP inside Schedule I by identity (51 TexReg 4597).
THCA belongs to a separate Texas instrument. The consumable-hemp rules have measured total delta-9 as (0.877 × THCA) + delta-9 since 2026-03-31, which effectively removes conventional THCA flower from the Texas hemp program (25 TAC §300.101(1), §300.302(b); Texas State Law Library cannabis guide). Combining the March rule and July notice into one event produces the wrong analysis.
The full Texas position, including the pending state and federal cases, is maintained at what Texas requires of a retailer today. No consumable product links appear on this page because a Texas compliance article is not a sales route into cannabinoid inventory.
The federal change on 2026-11-12
Section 781 of P.L. 119-37 takes effect 2026-11-12 and changes the federal hemp definition in three ways: it replaces the delta-9-only test with total THC at 0.3% dry weight, inclusive of THCA and delta-8; it caps finished products at 0.4 mg total THC per container; and it excludes cannabinoids not naturally produced by the plant along with naturally occurring cannabinoids synthesized outside the plant (CRS IF13136).
The U.S. Hemp Roundtable, an industry advocacy group, estimates that roughly 95% of existing hemp-derived cannabinoid products would fall outside the rewritten definition. That is an interested-party estimate rather than an agency count, and it is attributed here for that reason.
On 2026-08-08, the Senate passed H.R. 6500 containing proposed one-month partial-delay language. The 90–6 vote was passage of the continuing resolution, not a vote on hemp; the hemp language survived a 61–32 motion to table Senator Budd’s amendment #6747. That proposed delay language was not enacted as part of P.L. 119-37. Section 781 of H.R. 5371, enacted as P.L. 119-37 on 2025-11-12, sets 2026-11-12 as the effective date for the hemp provisions.
The maintained explanation is the federal change, in full. It records congressional movement rather than freezing a proposed delay into buyer documentation.
The container definition absent from the reviewed record
FDA was expected to publish cannabinoid lists and a definition of “container” by approximately 2026-02-10 under §781 of P.L. 119-37. The sources reviewed through 2026-08-17 contained neither those anticipated lists nor an FDA definition of “container” (CRS IF13136).
Because the sources reviewed through 2026-08-17 contained no FDA definition of "container," this page does not decide which packaging layer controls or assert later agency activity.
A COA can report total THC. Manufacturing records can document whether a cannabinoid was extracted or converted. Neither document supplied the authoritative packaging definition absent from the sources reviewed through 2026-08-17. That record gap is examined in why the container question remains open.
What an evidence file can close today
- The product and package configuration can be matched to the purchase order.
- The batch and dates can be matched across package and report.
- The laboratory and accreditation can be identified.
- The potency and named panels can be read from the COA.
- The label route can be tested on the physical package.
- The Texas packaging and age-control requirements can be mapped to the actual retail process (25 TAC §300.405, §300.701).
- The manufacturing process can document whether a cannabinoid was produced outside the plant for the federal origin test in §781 of P.L. 119-37 (CRS IF13136).
What remains open
- The federal container unit. The sources reviewed through 2026-08-17 contained no FDA definition of the term anticipated by §781 (CRS IF13136).
- The proposed federal delay. The Senate passed proposed one-month partial-delay language in H.R. 6500 on 2026-08-08. That language was not enacted as part of P.L. 119-37, which sets 2026-11-12 as the effective date.
- The Texas litigation. At the 2026-08-17 verification, the court had denied temporary emergency relief in the federal challenge to 51 TexReg 4597. This article does not assert later docket activity (Texas Tribune, 2026-08-10).
This is also why the current Texas retail registration fee is not stated here. The adopted rule, reported service-charge figure, pre-March fee, and injunction history do not yield one verified amount currently charged. A supplier-vetting page cannot repair a contested figure by picking one.
Retail bags are a separate category
Smell-proof bags can sit beside compliant consumables without being compliance packaging. The FireBar Labs Essential Mini Duffle Bag represents lockable household storage, the FireBar Labs Essential Crossbody Bag represents body-worn carry, and the Executive Tech Hybrid Duffle Bag represents structured work-and-travel carry. Those are independent product benefits.
FireBar Labs bags are smell-proof throughout the bag, with activated coconut charcoal built into the construction. They are field-tested in real-world conditions, not lab tested. Executive Tech uses multi-layered high-performance waterproof vegan leather; equipped models use a USB-C pass-through with the owner’s power bank inside and the phone connected outside while the bag stays closed. None of those claims relies on a consumable COA.
For the commercial side of that category, which assortment actually turns covers format, display, and customer questions without importing cannabinoid compliance claims into bag copy.
Frequently asked questions
What laboratory evidence does Texas require for consumable hemp?
A batch COA from an ISO/IEC 17025 accredited laboratory under 25 TAC §300.301, including delta-9 THC percentage, total delta-9 THC, and total THC per container under §300.301(d)(12) (Texas State Law Library cannabis guide).
Does a QR code establish compliance?
No. Texas requires a conspicuous URL reaching the COA in three steps or fewer under 25 TAC §300.402(a). The code is a route; the destination, product match, batch connection, and report contents establish whether the route reaches relevant evidence.
Can a lockable smell-proof bag count as child-resistant consumable packaging?
Not by FireBar Labs claim. Texas packaging duties apply to the retail consumable package under 25 TAC §300.405. FireBar Labs bags are field-tested carry goods and are not certified child-resistant packaging.
What age gate applies in Texas?
Texas rules prohibit selling, delivering, or offering consumable hemp to a person under 21 and require review of valid identification before the sale completes (25 TAC §300.701, §300.101(26); Executive Order GA-56).
What changes federally on 2026-11-12?
Section 781 of H.R. 5371, enacted as P.L. 119-37 on 2025-11-12, takes effect on 2026-11-12 and moves hemp to a total-THC test at 0.3% dry weight, caps finished products at 0.4 mg total THC per container, and excludes cannabinoids synthesized outside the plant (CRS IF13136). On 2026-08-08, the Senate passed H.R. 6500 containing proposed one-month partial-delay language; that language was not enacted as part of P.L. 119-37.
Has FDA defined container?
The sources reviewed through 2026-08-17 contained neither the anticipated FDA definition nor the cannabinoid lists after the approximate 2026-02-10 deadline under §781 of P.L. 119-37. This article does not assert later agency activity (CRS IF13136).
Change log
- 2026-08-19 — date-gate de-temporalization. Replaced live legislative, docket, and FDA-publication status wording with the enacted 2026-11-12 effective date and records verified through 2026-08-17; no later outcome is asserted.
- 2026-08-17 — packaging interpretation removed. The page states only that the sources reviewed through that date contained no FDA definition of "container."
- 2026-08-16 — initial verification. Texas testing, label, packaging, age-verification, potency, and schedule claims checked against 25 TAC ch. 300, Executive Order GA-56, 51 TexReg 4597, and the Texas State Law Library guide. Federal transition claims checked against §781 of P.L. 119-37 and Congressional Research Service IF13136. At that verification, the court had denied temporary emergency relief; this article does not assert later docket activity.
About this article
This article is general information about the law, published for educational purposes. It is not a substitute for the advice of an attorney. Laws change and vary by state — consult an attorney licensed in your jurisdiction about your specific situation. Jurisdiction covered: Texas and United States federal law. Last verified: 2026-08-17.
What we checked for this page: 25 TAC ch. 300; Executive Order GA-56; 51 TexReg 4597; the Texas State Law Library cannabis guide updated 2026-08-05; §781 of P.L. 119-37; Congressional Research Service IF13136; and Texas Tribune reporting on the federal challenge and denied temporary restraining order. Published by The FireBar Labs Team.
Explore FireBar Labs
Buying for a shop? Open the FireBar Labs wholesale catalog or trade account page, and send questions to support@firebarlabs.com.
Share:
Continue Reading
The QR Code on the Package: Why Lab Results Should Be Three Clicks Away
You Bought It Legally. Then Texas Rescheduled It.